Literature DB >> 12600705

Stress-induced hyperthermia and anxiety: pharmacological validation.

Berend Olivier1, Theo Zethof, Tommy Pattij, Meg van Boogaert, Ruud van Oorschot, Christina Leahy, Ronald Oosting, Arjan Bouwknecht, Jan Veening, Jan van der Gugten, Lucianne Groenink.   

Abstract

When mammals, including man, are confronted with a stressful event, their core body temperature rises, stress-induced hyperthermia. In mice, the stress-induced hyperthermia procedure has been developed to measure antistress or anxiolytic-like effects of psychoactive drugs. Group-housed and singly housed versions of the stress-induced hyperthermia generate comparable results. Because the number of animals needed to perform an experiment is much lower in the singly housed versus the group-housed procedure, the former is the test of choice for pharmacological testing. A typical stress-induced hyperthermia test starts with an injection 60 min before the first rectal temperature measurement (T(1)), followed by a second temperature measurement (T(2)) 10-15 min later. The difference DeltaT (=T(2)-T(1)) is the stress-induced hyperthermia. The procedure also measures the intrinsic activity of drugs on the basal body temperature and DeltaT is relatively independent from the intrinsic temperature effects of drugs. Anxiolytic drugs (benzodiazepines, 5-HT(1A) receptor agonists, alcohol) reduce DeltaT suggestive of anxiolytic-like effects. Because the parameter measured for anxiety in the stress-induced hyperthermia procedure is not dependent on locomotor activity, like in almost all other anxiety tests, the stress-induced hyperthermia procedure is an attractive addition to tests in the anxiety field. Because the stress-induced hyperthermia is also present with a comparable pharmacological profile in females, this procedure has a wide species and gender validity. The procedure was applied in various genetically modified mice [5-HT(1A) and 5-HT(1B) receptor knockout (KO) mice and corticotropin-releasing hormone overexpressing (CRH-OE) mice] to study phenotypic influences of the various mutations on aspects of anxiety. The stress-induced hyperthermia test in singly housed male and female mice appears a useful and extremely simple test to measure effects of drugs on certain aspects of anxiety or to help to determine phenotypic differences in mutant mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600705     DOI: 10.1016/s0014-2999(03)01326-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  44 in total

1.  Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.

Authors:  David T Dao; Pamela Belmonte Mahon; Xiang Cai; Colleen E Kovacsics; Robert A Blackwell; Michal Arad; Jianxin Shi; Peter P Zandi; Patricio O'Donnell; James A Knowles; Myrna M Weissman; William Coryell; William A Scheftner; William B Lawson; Douglas F Levinson; Scott M Thompson; James B Potash; Todd D Gould
Journal:  Biol Psychiatry       Date:  2010-08-17       Impact factor: 13.382

2.  Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications.

Authors:  Robert H Ring; Jessica E Malberg; Lisa Potestio; Julia Ping; Steve Boikess; Bin Luo; Lee E Schechter; Stacey Rizzo; Zia Rahman; Sharon Rosenzweig-Lipson
Journal:  Psychopharmacology (Berl)       Date:  2006-01-18       Impact factor: 4.530

Review 3.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

4.  The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.

Authors:  Xia Li; Katarzyna Kaczanowska; M G Finn; Athina Markou; Victoria B Risbrough
Journal:  Neuropharmacology       Date:  2015-05-19       Impact factor: 5.250

5.  Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.

Authors:  Celia Goeldner; Will Spooren; Jürgen Wichmann; Eric P Prinssen
Journal:  Psychopharmacology (Berl)       Date:  2012-01-18       Impact factor: 4.530

6.  Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands.

Authors:  Linda M Rorick-Kehn; John C Hart; David L McKinzie
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

7.  Housing environment modulates physiological and behavioral responses to anxiogenic stimuli in trait anxiety male rats.

Authors:  R Ravenelle; H B Santolucito; E M Byrnes; J J Byrnes; S T Donaldson
Journal:  Neuroscience       Date:  2014-04-05       Impact factor: 3.590

8.  5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia.

Authors:  Christiaan H Vinkers; Ruud van Oorschot; S Mechiel Korte; Berend Olivier; Lucianne Groenink
Journal:  Psychopharmacology (Berl)       Date:  2010-06-10       Impact factor: 4.530

9.  Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.

Authors:  Jacob P R Jacobsen; Elsebet Ø Nielsen; Rene Hummel; John Paul Redrobe; Naheed Mirza; Pia Weikop
Journal:  Psychopharmacology (Berl)       Date:  2008-05-22       Impact factor: 4.530

10.  Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide.

Authors:  Alexa Mead; Ming Li; Shitij Kapur
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.